| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harrow, Inc.'s insiders have reduced their positions by a net 11,250 shares worth roughly $450K.
HROW sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.68M | $146.05M | - | |
| CEO | 3.00M | $90.48M | - | |
| CFO | 814.7K | $24.36M | - | |
| Dir | 1.0K | $31.1K | - | |
| Dir | 1.0K | $31.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2019 | Kammer Robert J | - | Sell | 6,500 | $5.67 | $36,855.00 | -0.8% | |
| Aug 12, 2019 | Kammer Robert J | - | Sell | 6,500 | $6.89 | $44,785.00 | -0.8% | |
| Jul 15, 2019 | Kammer Robert J | Director | Sell | 6,500 | $7.91 | $51,415.00 | -0.8% | |
| Jun 3, 2019 | Kammer Robert J | Director | Sell | 10,000 | $5.78 | $57,800.00 | -1.2% | |
| May 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $4.57 | $45,700.00 | -1.2% | |
| Apr 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $4.77 | $47,700.00 | -1.2% | |
| Mar 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $6.91 | $69,100.00 | -1.1% | |
| Feb 1, 2019 | Kammer Robert J | Director | Sell | 10,000 | $5.86 | $58,600.00 | -1.1% | |
| Jan 2, 2019 | Kammer Robert J | Director | Sell | 10,000 | $5.33 | $53,300.00 | -1.1% | |
| Dec 3, 2018 | Kammer Robert J | Director | Sell | 10,000 | $4.64 | $46,400.00 | -1.1% |